title: T-cell-mediated immunity in persistent Mycobacterium intracellulare infections in mice.
abstract: Growth of mouse-virulent Mycobacterium intracellulare D673 and TMC 1405 in the lung was affected by T-cell depletion in susceptible C57BL/6 mice. Significant differences also occurred between the growth patterns seen in congenitally athymic (nu/nu) mice and their nu/+ littermates. Treatment of the mice with an immunosuppressive regimen of cyclosporin A (75 mg/kg of body weight per day subcutaneously) provided further evidence of the importance of T cells in controlling growth of M. intracellulare in the normal host. Adoptive transfer experiments indicated the presence of a T-cell-mediated specific protective immunity against a subsequent M. intracellulare challenge when transfer was carried out 3 weeks after immunization of the donor host. At this time, cross-protective immunity was also observed against a virulent M. tuberculosis challenge. There was no difference in the rate of growth by M. intracellulare as challenge in Mycobacterium bovis BCG-activated or normal peritoneal macrophages from C57BL/6 mice tested in vitro during a 7-day period. However, M. tuberculosis growth rates were decreased substantially in the BCG-activated macrophages. These studies suggest that mice infected with M. intracellulare do not eliminate the infection, because this organism can resist the bactericidal activity of the T-cell-activated macrophage better than M. tuberculosis can.
authors.affiliation: Trudeau Institute, Inc., Saranac Lake, New York 12983.
authors.forename: T
authors.initials: T
authors.lastname: Takashima
authors.forename: F M
authors.initials: FM
authors.lastname: Collins
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000276:immunology; D002908:Chronic Disease; D003524:Cyclosporins / Q000627:therapeutic use; D007111:Immunity, Cellular; D007116:Immunization, Passive; D008168:Lung / Q000382:microbiology; D008264:Macrophages / Q000382:microbiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000276:immunology*; D015269:Mycobacterium avium Complex / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014611:Vaccination
chemical_list: D001500:BCG Vaccine; D003524:Cyclosporins